-+ 0.00%
-+ 0.00%
-+ 0.00%

Fulcrum Therapeutics director Joshua Lehrer-Graiwer files initial beneficial ownership statement

PUBT·05/01/2026 20:11:11
Listen to the news
Fulcrum Therapeutics director Joshua Lehrer-Graiwer files initial beneficial ownership statement
  • Fulcrum Therapeutics reported Joshua Lehrer-Graiwer as a director in an initial Form 3 filing dated April 23, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-201437), on May 01, 2026, and is solely responsible for the information contained therein.